Malvern, Pa.  Webwire-Thursday October 29, 2015 – Angelina Jolie’s surgeon Dr Kristi Funk has reveled in detail the treatment the 37 year old actress underwent before, during and after her preventive mastectomy procedure in a blog post on the Pink Lotus Breast Cancer Website (https://pinklotus.com). Dr Funk says that the actress Angelina Jolie followed a […]

Malvern, Pa.  November  2014 – DermAvance Pharmaceuticals a privately held pharmaceutical company specializing in advanced technology applications for aesthetic products, today announced that the Food and Drug Administration (FDA)  has approved the Investigational Device Exemption (IDE) for DA-13-007-Dermal Filler to begin pivotal trials in the US. Dermal Fillers are used to reverse changes associated with […]

Malvern, Pa. March 2014-DermAvance Pharmaceuticals a privately held pharmaceutical company specializing in advanced technology for aging skin, today announce the publication of a clinical study in humans demonstrating the efficacy of a new topical nano-hyaluronic acid product line called Hyalogy. The study was the lead article published in The Journal of Clinical Aesthetic Dermatology March […]

BERYWN, Pa., May 1 /PRNewswire/ — DermAvance Pharmaceuticals, a privately held pharmaceutical company specializing in advanced technology applications for skin health and cosmetic dermatology, today announced it had received an investment from Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP). These funds are part of a Series B financing that will be used to complete […]

Berywn, PA, August 15, 2006 – DermAvance Pharmaceuticals, a privately held pharmaceutical company specializing in advanced technology applications for skin health and cosmetic dermatology, today announced the acquisition of the North American rights for the Hyalogy™ Total Skin Care Line from Forlle’d in Japan. Hyalogy™ P-effect represents a novel breakthrough formulation technology, using a proprietary […]